PGBD2
geneOn this page
Summary
PGBD2 (piggyBac transposable element derived 2, HGNC:19399) is a protein-coding gene on chromosome 1q44, encoding PiggyBac transposable element-derived protein 2 (Q6P3X8).
The piggyBac family of proteins, found in diverse animals, are transposases related to the transposase of the canonical piggyBac transposon from the moth, Trichoplusia ni. This family also includes genes in several genomes, including human, that appear to have been derived from the piggyBac transposons. This gene belongs to the subfamily of piggyBac transposable element derived (PGBD) genes. The PGBD proteins appear to be novel, with no obvious relationship to other transposases, or other known protein families. The exact function of this gene is not known. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 267002 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 118 total — 1 pathogenic
- MANE Select transcript:
NM_170725
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19399 |
| Approved symbol | PGBD2 |
| Name | piggyBac transposable element derived 2 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000185220 |
| Ensembl biotype | protein_coding |
| Entrez | 267002 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000329291, ENST00000355360, ENST00000462488, ENST00000935434
RefSeq mRNA: 2 — MANE Select: NM_170725
NM_001017434, NM_170725
CCDS: CCDS31128, CCDS31129
Canonical transcript exons
ENST00000329291 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001312561 | 248916602 | 248919146 |
| ENSE00001637224 | 248906235 | 248906342 |
| ENSE00003610993 | 248913816 | 248913879 |
Expression profiles
Bgee: expression breadth ubiquitous, 223 present calls, max score 80.67.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.5115 / max 54.2742, expressed in 1628 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9662 | 4.5027 | 1626 |
| 9663 | 0.0089 | 3 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 80.67 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.49 | gold quality |
| left testis | UBERON:0004533 | 79.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.07 | gold quality |
| testis | UBERON:0000473 | 78.39 | gold quality |
| right testis | UBERON:0004534 | 78.33 | gold quality |
| leukocyte | CL:0000738 | 78.30 | gold quality |
| monocyte | CL:0000576 | 78.20 | gold quality |
| oocyte | CL:0000023 | 77.92 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.32 | gold quality |
| rectum | UBERON:0001052 | 76.80 | gold quality |
| spleen | UBERON:0002106 | 76.73 | gold quality |
| lymph node | UBERON:0000029 | 76.49 | gold quality |
| body of pancreas | UBERON:0001150 | 75.94 | gold quality |
| right lobe of liver | UBERON:0001114 | 75.91 | gold quality |
| myocardium | UBERON:0002349 | 75.83 | silver quality |
| gingival epithelium | UBERON:0001949 | 75.80 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 75.50 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 75.34 | gold quality |
| upper arm skin | UBERON:0004263 | 75.31 | silver quality |
| right lobe of thyroid gland | UBERON:0001119 | 75.13 | gold quality |
| gingiva | UBERON:0001828 | 75.13 | gold quality |
| vermiform appendix | UBERON:0001154 | 74.91 | gold quality |
| pancreas | UBERON:0001264 | 74.86 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 74.86 | silver quality |
| islet of Langerhans | UBERON:0000006 | 74.84 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 74.69 | silver quality |
| pancreatic ductal cell | CL:0002079 | 74.52 | silver quality |
| gall bladder | UBERON:0002110 | 74.45 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.44 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting PGBD2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-4666B | 99.64 | 68.69 | 1282 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-5004-3P | 99.54 | 68.27 | 1371 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-223-5P | 99.24 | 68.82 | 1206 |
| HSA-MIR-4687-5P | 99.14 | 66.26 | 488 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
PiggyBac transposable element-derived protein 2 — Q6P3X8 (reviewed: Q6P3X8)
All UniProt accessions (1): Q6P3X8
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P3X8-1 | 1 | yes |
| Q6P3X8-2 | 2 |
RefSeq proteins (2): NP_001017434, NP_733843* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029526 | PGBD | Domain |
| IPR052638 | PiggyBac_TE-derived | Family |
Pfam: PF13843
UniProt features (3 total): chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P3X8-F1 | 83.55 | 0.60 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
chr1q44, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CBX5_TARGET_GENES, ID2_TARGET_GENES, KAT2A_TARGET_GENES, NCOA6_TARGET_GENES, SFMBT1_TARGET_GENES, SNIP1_TARGET_GENES, TOP2B_TARGET_GENES, ZNF2_TARGET_GENES, ZNF274_TARGET_GENES, ZNF391_TARGET_GENES, ZNF407_TARGET_GENES, ZNF524_TARGET_GENES, ZNF592_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): sequence-specific DNA binding (GO:0043565)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA binding | 1 |
Protein interactions and networks
STRING
344 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PGBD2 | ZBED8 | Q8IZ13 | 617 |
| PGBD2 | THAP9 | Q9H5L6 | 555 |
| PGBD2 | POGK | Q9P215 | 524 |
| PGBD2 | PGBD5 | Q8N414 | 513 |
| PGBD2 | ZNF862 | O60290 | 510 |
| PGBD2 | BET1L | Q9NYM9 | 481 |
| PGBD2 | ERCC6 | Q03468 | 480 |
| PGBD2 | ZNF672 | Q499Z4 | 473 |
| PGBD2 | NAIF1 | Q69YI7 | 453 |
| PGBD2 | ZNF385D | Q9H6B1 | 447 |
| PGBD2 | HARBI1 | Q96MB7 | 445 |
| PGBD2 | GNL1 | P36915 | 440 |
| PGBD2 | TP53TG3 | Q9ULZ0 | 398 |
| PGBD2 | TRPC4AP | Q8TEL6 | 386 |
| PGBD2 | GIN1 | Q9NXP7 | 384 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PGBD1 | SCAND1 | psi-mi:“MI:0914”(association) | 0.940 |
| PGBD1 | ZNF24 | psi-mi:“MI:0914”(association) | 0.900 |
| PGBD1 | ZNF213 | psi-mi:“MI:0914”(association) | 0.530 |
| FAXC | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| FAXC | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): PGBD2 (Affinity Capture-MS), PGBD2 (Affinity Capture-MS), PGBD2 (Affinity Capture-MS), PGBD2 (Affinity Capture-MS), PGBD2 (Protein-peptide), TFRC (Cross-Linking-MS (XL-MS)), PGBD2 (Affinity Capture-MS)
ESM2 similar proteins: A0A2P1BRP3, A0A2P1BRQ0, A0ZSK3, A0ZSK4, A4IFA3, A4Z943, A4Z944, A4Z945, B2RD01, B2RRL2, O43422, O60108, O96006, P0CF97, P12258, P34601, P49777, Q09575, Q0VBL1, Q17RP2, Q2T9S8, Q3EBC8, Q49AG3, Q4R6P1, Q4W5G0, Q5SVZ6, Q6EKJ0, Q6NT04, Q6P3X8, Q6R2W3, Q7L775, Q7M3K2, Q7TSV6, Q86UP8, Q8BUZ3, Q8BV66, Q8CBA2, Q8IY51, Q8IZ13, Q8TCP9
Diamond homologs: F8VPZ5, P0DP91, Q03468, Q6P3X8, Q8N328, Q96JS3, A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
118 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 109 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 442386 | GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3 | Pathogenic |
SpliceAI
916 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:248913813:CAGGT:C | acceptor_loss | 1.0000 |
| 1:248913814:A:AG | acceptor_gain | 1.0000 |
| 1:248913814:AGGT:A | acceptor_loss | 1.0000 |
| 1:248913815:G:GG | acceptor_gain | 1.0000 |
| 1:248913875:TCCAG:T | donor_loss | 1.0000 |
| 1:248913876:CCAG:C | donor_loss | 1.0000 |
| 1:248913877:CAGG:C | donor_loss | 1.0000 |
| 1:248913878:AGGTA:A | donor_loss | 1.0000 |
| 1:248913879:GGT:G | donor_loss | 1.0000 |
| 1:248913880:GT:G | donor_loss | 1.0000 |
| 1:248913881:T:G | donor_loss | 1.0000 |
| 1:248913815:GGTT:G | acceptor_gain | 0.9900 |
| 1:248916601:GAGAT:G | acceptor_gain | 0.9900 |
| 1:248916999:C:G | donor_gain | 0.9900 |
| 1:248906490:G:GT | donor_gain | 0.9800 |
| 1:248906517:G:GT | donor_gain | 0.9800 |
| 1:248913814:AG:A | acceptor_gain | 0.9800 |
| 1:248913815:GG:G | acceptor_gain | 0.9800 |
| 1:248913815:GGTTC:G | acceptor_gain | 0.9800 |
| 1:248916600:A:AG | acceptor_gain | 0.9800 |
| 1:248916601:G:GG | acceptor_gain | 0.9800 |
| 1:248916601:GA:G | acceptor_gain | 0.9800 |
| 1:248913811:TACAG:T | acceptor_gain | 0.9700 |
| 1:248914504:G:GT | donor_gain | 0.9700 |
| 1:248906341:AG:A | donor_loss | 0.9600 |
| 1:248906342:GGTAG:G | donor_loss | 0.9600 |
| 1:248906343:G:GC | donor_loss | 0.9600 |
| 1:248906344:T:A | donor_loss | 0.9600 |
| 1:248906485:G:GT | donor_gain | 0.9600 |
| 1:248906491:A:T | donor_gain | 0.9600 |
AlphaMissense
3942 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:248918304:T:A | C574S | 0.997 |
| 1:248918305:G:C | C574S | 0.997 |
| 1:248918340:T:C | F586L | 0.997 |
| 1:248918342:C:A | F586L | 0.997 |
| 1:248918342:C:G | F586L | 0.997 |
| 1:248918271:T:A | C563S | 0.996 |
| 1:248918271:T:C | C563R | 0.996 |
| 1:248918272:G:C | C563S | 0.996 |
| 1:248918304:T:C | C574R | 0.996 |
| 1:248918337:T:C | C585R | 0.996 |
| 1:248918352:C:G | H590D | 0.996 |
| 1:248918280:T:A | C566S | 0.995 |
| 1:248918281:G:C | C566S | 0.995 |
| 1:248918326:T:A | V581D | 0.995 |
| 1:248918337:T:A | C585S | 0.995 |
| 1:248918338:G:C | C585S | 0.995 |
| 1:248918280:T:C | C566R | 0.994 |
| 1:248918313:T:A | C577S | 0.994 |
| 1:248918314:G:C | C577S | 0.994 |
| 1:248918354:C:A | H590Q | 0.994 |
| 1:248918354:C:G | H590Q | 0.994 |
| 1:248917149:A:C | S189R | 0.993 |
| 1:248917151:T:A | S189R | 0.993 |
| 1:248917151:T:G | S189R | 0.993 |
| 1:248918313:T:C | C577R | 0.993 |
| 1:248917185:T:A | W201R | 0.992 |
| 1:248917185:T:C | W201R | 0.992 |
| 1:248918240:C:A | H552Q | 0.992 |
| 1:248918240:C:G | H552Q | 0.992 |
| 1:248918305:G:A | C574Y | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000051404 (1:248872252 A>G), RS1000056410 (1:248899828 A>G), RS1000145049 (1:248915581 C>A,T), RS1000171504 (1:248885828 G>A), RS1000186437 (1:248920341 C>G,T), RS1000291658 (1:248888973 A>G), RS1000300462 (1:248893121 A>G), RS1000323028 (1:248920526 TTTTC>T), RS1000323416 (1:248887714 G>T), RS1000342186 (1:248929515 G>A), RS1000346542 (1:248874757 A>G), RS1000346544 (1:248906922 G>A), RS1000365927 (1:248924696 GACA>G), RS1000506013 (1:248916556 G>C), RS1000519278 (1:248919113 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006462_4 | Uterine fibroids | 4.000000e-09 |
| GCST009560_3 | Decreased low contrast letter acuity in multiple sclerosis | 2.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008385 | visual acuity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | decreases expression | 1 |
| licochalcone B | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thimerosal | increases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): uterine corpus leiomyoma